Fragment-size selection can increase fetal representation because fetal and maternal DNA fragments may differ in length. A method separates or preferentially retains fragments within a size range associated with a higher fetal fraction. This reduces the maternal DNA background entering downstream molecular analysis, potentially improving the sensitivity and analytical accuracy of prenatal assays.
Placental-specific DNA methylation provides a molecular distinction between fetal-derived and maternal DNA. Enrichment strategies can exploit methylation patterns that are associated with placental material, allowing fetal signals to be concentrated within a mixed sample. This approach complements physical fragment-based selection and can improve the relative fetal fraction available for subsequent genetic analysis.
Targeted sequence capture enriches selected genetic sequences rather than relying primarily on fragment length or methylation differences. By concentrating particular regions before analysis, it can direct the assay toward sequences relevant to chromosomal abnormalities, inherited variants, or pregnancy-related biomarkers. The strategy therefore links enrichment more directly to the genetic targets being investigated.
A typical workflow begins with a mixed biological sample, most commonly maternal plasma containing cell-free DNA. The material undergoes an enrichment step based on fragment size, placental-specific methylation, targeted sequence capture, or another supported selection principle. The enriched fraction then proceeds to molecular analysis, where improved fetal representation can support more accurate interpretation.
Enrichment can support analyses aimed at detecting chromosomal abnormalities, inherited genetic variants, and other pregnancy-related biomarkers. Increasing the relative fetal fraction gives these assays more fetal-derived material to evaluate against the abundant maternal background. In bioengineering applications, this supports the development of sensitive molecular tests for noninvasive prenatal screening and precision diagnostics.
The approach presents a bioengineering challenge involving selective recovery of a low-abundance signal from a complex biological mixture. Designing effective enrichment methods can improve analytical accuracy while reducing dependence on invasive sampling. It also helps engineers develop molecular assays that are better suited to prenatal screening, where fetal genetic information must be measured through maternal biological material.